Literature DB >> 14636581

Active and inactive orientations of the transmembrane and cytosolic domains of the erythropoietin receptor dimer.

Nadine Seubert1, Yohan Royer, Judith Staerk, Katharina F Kubatzky, Virginie Moucadel, Shyam Krishnakumar, Steven O Smith, Stefan N Constantinescu.   

Abstract

Binding of erythropoietin to the erythropoietin receptor (EpoR) extracellular domain orients the transmembrane (TM) and cytosolic regions of the receptor dimer into an unknown activated conformation. By replacing the EpoR extracellular domain with a dimeric coiled coil, we engineered TM EpoR fusion proteins where the helical TM domains were constrained into seven possible relative orientations. We identify one dimeric TM conformation that imparts full activity to the cytosolic domain of the receptor and signals via JAK2, STAT proteins, and MAP kinase, one partially active orientation that preferentially activates MAP kinase, and one conformation corresponding to the inactive receptor. The active and inactive conformations were independently identified by computational searches for low-energy TM dimeric structures. We propose a specific EpoR-activated interface and suggest its use for structural and signaling studies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14636581     DOI: 10.1016/s1097-2765(03)00389-7

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  67 in total

Review 1.  Single-spanning transmembrane domains in cell growth and cell-cell interactions: More than meets the eye?

Authors:  Pierre Hubert; Paul Sawma; Jean-Pierre Duneau; Jonathan Khao; Jérôme Hénin; Dominique Bagnard; James Sturgis
Journal:  Cell Adh Migr       Date:  2010-04-20       Impact factor: 3.405

2.  Mutational profile of childhood myeloproliferative neoplasms.

Authors:  A Karow; R Nienhold; P Lundberg; E Peroni; M C Putti; M L Randi; R C Skoda
Journal:  Leukemia       Date:  2015-07-30       Impact factor: 11.528

Review 3.  Erythropoietin receptor response circuits.

Authors:  Don M Wojchowski; Pradeep Sathyanarayana; Arvind Dev
Journal:  Curr Opin Hematol       Date:  2010-05       Impact factor: 3.284

4.  Selection of antibodies that regulate phenotype from intracellular combinatorial antibody libraries.

Authors:  Hongkai Zhang; Ian A Wilson; Richard A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-10       Impact factor: 11.205

5.  Two modes of beta-receptor recognition are mediated by distinct epitopes on mouse and human interleukin-3.

Authors:  Shamaruh Mirza; Jinglong Chen; Bin Wen; Cameron L Ewens; Jin Dai; James M Murphy; Ian G Young
Journal:  J Biol Chem       Date:  2010-05-14       Impact factor: 5.157

6.  Expression of a homodimeric type I cytokine receptor is required for JAK2V617F-mediated transformation.

Authors:  Xiaohui Lu; Ross Levine; Wei Tong; Gerlinde Wernig; Yana Pikman; Sara Zarnegar; D Gary Gilliland; Harvey Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

Review 7.  Interaction and conformational dynamics of membrane-spanning protein helices.

Authors:  Dieter Langosch; Isaiah T Arkin
Journal:  Protein Sci       Date:  2009-07       Impact factor: 6.725

Review 8.  β-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism.

Authors:  Yelena Ginzburg; Stefano Rivella
Journal:  Blood       Date:  2011-07-18       Impact factor: 22.113

9.  Symmetric signaling by an asymmetric 1 erythropoietin: 2 erythropoietin receptor complex.

Authors:  Yingxin L Zhang; Mala L Radhakrishnan; Xiaohui Lu; Alec W Gross; Bruce Tidor; Harvey F Lodish
Journal:  Mol Cell       Date:  2009-01-30       Impact factor: 17.970

10.  Ligand-independent homomeric and heteromeric complexes between interleukin-2 or -9 receptor subunits and the gamma chain.

Authors:  Yaniv Malka; Tekla Hornakova; Yohan Royer; Laurent Knoops; Jean-Christophe Renauld; Stefan N Constantinescu; Yoav I Henis
Journal:  J Biol Chem       Date:  2008-10-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.